ABT stock forecast: what analysts expect
Wall Street analysts covering Abbott Laboratories currently rate the stock a Buy on average, with a mean 12-month price target of $118.42 — +6.8% versus the last price of $110.91. Targets reflect analyst opinion, not a guarantee.
ABT historical returns
Based on monthly dividend-adjusted prices. See the full breakdown on what if you had invested in ABT.
ABT annual returns by year
Congress trading in ABT
36 members of Congress have disclosed trading ABT — 38 purchases and 24 sales worth an estimated $872,502. Most recent disclosure: Jul 17, 2026.
See who in Congress traded ABT →About Abbott Laboratories
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company offers generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, hypertriglyceridemia, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also provides laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion serology testing; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; and drug and alcohol test. In addition, the company offers pediatric and adult nutritional products and infant formula; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices. The company was formerly known as Abbott Alkaloidal Company and changed its name to Abbott Laboratories in 1915. Abbott Laboratories was founded in 1888 and is based in Abbott Park, Illinois.
ABT Key Statistics
ABT in plain English
- P/E ratio (35.4) — how many dollars you pay for each $1 of ABT's yearly profit. That's a fairly normal range.
- ROE (10.58%) — how efficiently the company turns shareholders' money into profit. This is a middling level.
- Profit margin (11.65%) — of every $1 in sales, this is what's left as profit after all costs.
- Dividend yield (2.27%) — the cash payout you'd earn per year as a % of the share price, on top of any price gains.
ABT stock: frequently asked questions
What is Abbott Laboratories's stock price today?
Abbott Laboratories (ABT) last traded at $110.91 on the NYSE. Over the past 52 weeks the stock has traded between $81.97 and $137.49.
Is ABT stock a buy or a sell?
Wall Street analysts' consensus rating on ABT is "Buy", with an average 12-month price target of $118.42 — about +6.8% versus the current price of $110.91. Analyst targets are opinions, not guarantees; always do your own research.
How much would $1,000 invested in ABT 10 years ago be worth today?
A $1,000 investment in Abbott Laboratories made 10 years ago would be worth about $3,186 today (dividends reinvested) — a total return of 219%, or 12.3% per year.
Does ABT pay a dividend?
Yes. Abbott Laboratories currently pays a dividend yielding about 2.27% per year at today's share price.
What is ABT's P/E ratio?
ABT trades at a trailing price-to-earnings ratio of 35.4, and 18.3 times expected forward earnings. The P/E ratio tells you how many dollars investors pay for each $1 of the company's annual profit.
Do members of Congress trade ABT stock?
Yes — 36 members of Congress have disclosed trades in ABT under the STOCK Act, totaling 38 purchases and 24 sales worth an estimated $872,502.
What is Abbott Laboratories's ticker symbol?
Abbott Laboratories trades under the ticker symbol ABT on the NYSE.
Compare ABT with peers
Data last refreshed from public sources. Figures may be delayed. Not investment advice.